Generics (UK) Limited v AstraZeneca AB

[2025] EWHC 1012 (Pat)

Patents Court | 2025 · reported | England and Wales

Article published: 12 May 2025

It’s a fact of life that counsel sometimes aim personal criticism  at experts, either during a cross-examination or afterwards in their closing submissions. That is very uncomfortable for any expert, whose professional and sometime  personal reputation may be on the line.

 

So a recent patent case offers some comfort that however critical counsel may be in their comments judges take pains to look at the evidence that’s been given and weigh up any criticism against what an expert has actually done and said.

 

This full content of this article is available to TAE members.

Log in Become a TAE Member

Articles reflect the law and practice at the time of original publication, except where a dated update is shown. Subsequent developments may affect their relevance or accuracy. They are provided for general information and do not constitute legal or professional advice. Obtain appropriate advice on your particular circumstances. Full disclaimer.

← Browse all cases

Contact Us